A Study Comparing Effectiveness and Safety of SPIRA-A Anterior Lumbar Interbody Fusion Device to PEEK Anterior Lumbar Interbody Fusion Cage with rhBMP-2 in Instrumented Lumbar Fusions

Overview

Información sobre este estudio

The purpose of this study is to evaluate if SPIRA-A Anterior Lumbar Interbody Fusion Device is equivalent in effectiveness and safety to PEEK Anterior Lumbar Interbody Fusion Cage with rhBMP-2 when used in instrumented lumbar fusions.

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion Criteria:

  • Skeletally mature adults between 22 and 75 years old.
  • Subject has completed at least 6 months non-operative or conservative therapy.
  • Subject has signed and dated the informed consent prior to any study related procedures.
  • Subject must have back pain with radicular symptoms as evidenced by leg pain, which has been confirmed by history and physical exam.
  • Subject must have Degenerative Disc Disease confirmed by history and radiographic findings, stenosis, spondylolisthesis or scoliosis necessitating a Subject’s surgical procedure must involve disc(s) between L2 and S1.
  • Planned lumbar fusion at a one level only.
  • Subject is willing and able to participate in the study follow-up according to the protocol.
  • Subject is willing and able to comply with postoperative management program.

Exclusion Criteria:

  • Subject has a systemic infection such as AIDS, HIV, or active hepatitis.
  • Subject has an autoimmune disease.
  • Subject has significant metabolic disease that, in the surgeon’s opinion, might compromise bone growth such as osteoporosis, osteopenia, or osteomalacia.
  • Subject has history of malignancy.
  • Surgery for primary tumor, trauma or infection.
  • Subject requires 2 or more levels of fusion.
  • Subject has had previous spinal instrumentation or a previous interbody fusion procedure at the involved level.
  • Subject has spondylolisthesis ≥ grade 2.
  • If you are pregnant, plan to become pregnant or are breast feeding you cannot be in this study.

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus

Rochester, Minn.

Investigador principal de Mayo Clinic

Arjun Sebastian, M.D.

Cerrado para la inscripción

More information

Publicaciones

Publications are currently not available
.
CLS-20473848

Mayo Clinic Footer